GW Pharmaceuticals Receives Prestigious Queen’s Award for Innovation

GW Pharmaceuticals Receives Prestigious Queen’s Award for Innovation - | HempRevs

London, England’s GW Pharmaceuticals, the makers of the cannabis-derived anti-seizure medication Epidiolex, has won the Queen’s Award for Enterprise 2021 in the Innovation category. It’s the first medical cannabis company to receive the award, which is considered the most prestigious for U.K. businesses.

Dr. Geoffrey W Guy, GW founder and chairman, said the company was “honored” to receive the award and that when he and co-founder Dr. Brian Whittle founded the company 23 years ago, its mission “was to improve the lives of seriously ill patients by unlocking the potential of the cannabis plant through rigorous scientific investigations and extensive clinical trials in order to obtain regulatory approval for such medicines to benefit patients.”

GW CEO Justin Gover said over the two decades the company “established a world-leading position in cannabinoid science and brought breakthrough medicines to patients in a new frontier of medicine.”

“We are immensely proud to have that work and dedication recognized by the prestigious Queen’s Awards for Enterprise. Our continued commitment to research and development has resulted in the treatment of thousands of patients with our medicines, and the prospect of helping countless more families through our robust pipeline of early- and late-stage product candidates.” – Gover in a press release

The company said it has invested more than £1.3 billion (USD$1.8 billion) “in the research, development and infrastructure needed to bring novel, innovative medicines to patients.”

In the announcement in the London Gazette, the company was described as “harnessing cannabinoid science to create innovative, regulatory approved, world-first cannabis-based medicines to improve lives.” The Queen’s Awards are in their 55th year.

In January, GW said that in 2020, Epidiolex sales increased more than 70%. It is also conducting trials on a multiple sclerosis drug in the U.S., Nabiximols, and it hopes to achieve data from at least one of the trials this year.

Get daily cannabis business news updates. Subscribe

Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.

Sponsor message:

Thanks for reading our latest news article. Stay up to date on the latest hemp news, sourced and approved by HempRevs. If you have any questions or comments, please feel free to leave us a message in the comments!

Sign up for our weekly newsletter to stay up to date on the latest Industry news and follow our site for our next post!

Source Disclaimer: This article was was sourced from Ganjapreneur.com (the Original Publisher). In order to maintain the functionality, trust, and safety of HempRevs.com, the content sourced from the Original Publisher may have been altered. Read the original article here:
GW Pharmaceuticals Receives Prestigious Queen’s Award for Innovation

Latest Articles

Galaxy Treats Banner Ad - 300x600

Related Content

Leave A Reply

Please enter your comment!
Please enter your name here